IL194773A - Use of antisecretory protein for the preparation of a pharmaceutical preparation for the treatment of high intraocular pressure - Google Patents
Use of antisecretory protein for the preparation of a pharmaceutical preparation for the treatment of high intraocular pressureInfo
- Publication number
- IL194773A IL194773A IL194773A IL19477308A IL194773A IL 194773 A IL194773 A IL 194773A IL 194773 A IL194773 A IL 194773A IL 19477308 A IL19477308 A IL 19477308A IL 194773 A IL194773 A IL 194773A
- Authority
- IL
- Israel
- Prior art keywords
- manufacture
- treatment
- pharmaceutical composition
- intraocular hypertension
- antisecretory protein
- Prior art date
Links
- 206010020772 Hypertension Diseases 0.000 title 1
- 230000001262 anti-secretory effect Effects 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Dispersion Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0600932 | 2006-04-27 | ||
| PCT/SE2007/000414 WO2007126364A2 (en) | 2006-04-27 | 2007-04-27 | Use of antisecretory factors for treating intraocular hypertension |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL194773A0 IL194773A0 (en) | 2011-08-01 |
| IL194773A true IL194773A (en) | 2015-07-30 |
Family
ID=38561776
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL194773A IL194773A (en) | 2006-04-27 | 2008-10-22 | Use of antisecretory protein for the preparation of a pharmaceutical preparation for the treatment of high intraocular pressure |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US8207296B2 (https=) |
| EP (2) | EP2468292B8 (https=) |
| JP (2) | JP5284948B2 (https=) |
| KR (1) | KR20090040404A (https=) |
| CN (2) | CN102633863B (https=) |
| AU (1) | AU2007244004B2 (https=) |
| BR (1) | BRPI0710959B8 (https=) |
| CA (2) | CA2771087C (https=) |
| DK (2) | DK2468292T3 (https=) |
| ES (2) | ES2773945T3 (https=) |
| IL (1) | IL194773A (https=) |
| MX (1) | MX2008013769A (https=) |
| NZ (2) | NZ572255A (https=) |
| PL (2) | PL2015767T3 (https=) |
| RU (1) | RU2458703C2 (https=) |
| SG (1) | SG171602A1 (https=) |
| WO (1) | WO2007126364A2 (https=) |
| ZA (1) | ZA200809115B (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2015767T3 (pl) * | 2006-04-27 | 2016-05-31 | Lantmaennen As Faktor Ab | Zastosowanie czynnika przeciwwydzielniczego do leczenia nadciśnienia śródgałkowego |
| US9962424B2 (en) | 2007-04-27 | 2018-05-08 | Lantmännen As-Faktor Ab | Use of antisecretory factors (AF) for optimizing cellular uptake |
| EP2396024A4 (en) * | 2009-02-11 | 2013-02-27 | Lantmaennen As Faktor Ab | USE OF ANTISECRREATORY FACTORS (AF) FOR OPTIMIZATION OF CELLULAR ABSORPTION |
| WO2013050795A1 (en) * | 2011-10-03 | 2013-04-11 | Femtonics Kft. | Use of photoactive compounds |
| CA3036216A1 (en) * | 2012-12-20 | 2014-06-26 | Lantmannen As-Faktor Ab | Use of antisecretory factor (af) in glioblastoma treatment |
| CN107949392B (zh) * | 2015-07-10 | 2022-10-11 | 兰特门内阿斯-法克托尔公司 | 用于生产含高含量af-16的蛋黄的方法 |
| JP6999638B2 (ja) | 2016-07-18 | 2022-01-18 | ラントメネン・メディカル・アーベー | 抗分泌性因子１７ |
| CA3103164A1 (en) | 2018-06-28 | 2020-01-02 | Lantmannen Medical Ab | Antisecretory factor for use in treatment and/or prevention of acute respiratory failure |
| WO2020065091A1 (en) | 2018-09-28 | 2020-04-02 | Lantmännen Functional Foods Ab | A consumable product comprising malted wheat |
| WO2020065089A2 (en) | 2018-09-28 | 2020-04-02 | Lantmännen Functional Foods Ab | A consumable product comprising malted dehulled oat |
| CN115605214A (zh) | 2020-03-26 | 2023-01-13 | 兰特门内保健食品公司（Se） | 用于促进身体活动恢复的包含麦芽化谷物的可消耗产品 |
| US20240148709A1 (en) * | 2022-11-08 | 2024-05-09 | Aisa Pharma, Inc. | Methods of treating eye pain and eye disorders |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH682716A5 (de) | 1992-01-13 | 1993-11-15 | Christian Fricker | Benzo-Pyrone und/oder Dobesilat-Calcium enthaltende pharmazeutische Zusammensetzung. |
| US5585401A (en) * | 1994-12-09 | 1996-12-17 | The Reents Of The University Of California | Method for enhancing outflow of aqueous humor in treatment of glaucoma |
| SE508609C2 (sv) * | 1995-08-24 | 1998-10-19 | Rural Patent Svenska Ab | Antisekretorisk faktor - dess aminosyrasekvens, nubleinsyrasekvens och användning |
| AU732508B2 (en) * | 1996-01-26 | 2001-04-26 | Governing Council Of The University Of Toronto, The | Nucleic acids and proteins related to Alzheimer's disease, and uses therefor |
| SE9604251L (sv) | 1996-11-20 | 1997-12-22 | Svenska Lantmaennen Riksfoerbu | Födoämne som vid förtäring inducerar antisekretoriska proteiner |
| SE513496C2 (sv) * | 1998-12-17 | 2000-09-18 | Rural Patent Svenska Ab | NASP-berikad äggula samt dess användning |
| CN1335887A (zh) * | 1999-06-21 | 2002-02-13 | 印坎药物股份有限公司 | 血管抑制素∶一种Cys－Ser－Val－Thr－Cys－Gly特异性肿瘤细胞粘附受体 |
| RU2192898C1 (ru) * | 2001-08-16 | 2002-11-20 | Московский научно-исследовательский институт глазных болезней им. Гельмгольца | Способ лечения герпетического кератита с изъязвлением |
| GB0322645D0 (en) | 2003-09-26 | 2003-10-29 | Melacure Therapeutics Ab | Use of antisecretory factor peptides |
| MX2008013777A (es) * | 2006-04-27 | 2009-02-03 | Lantmaennen As Faktor Ab | Usos medicos adicionales de la proteina antisecretora. |
| PL2015767T3 (pl) * | 2006-04-27 | 2016-05-31 | Lantmaennen As Faktor Ab | Zastosowanie czynnika przeciwwydzielniczego do leczenia nadciśnienia śródgałkowego |
| BRPI0710858A2 (pt) * | 2006-04-27 | 2011-05-17 | Lantmonnen As Faktor Ab | uso de uma proteìna anti-secretora, um derivado, homólogo e/ou fragmento da mesma, tendo atividade anti-secretora, e/ou um sal farmaceuticamente ativo da mesma |
-
2007
- 2007-04-27 PL PL07748079T patent/PL2015767T3/pl unknown
- 2007-04-27 CN CN201210058790.XA patent/CN102633863B/zh not_active Expired - Fee Related
- 2007-04-27 DK DK12157100.4T patent/DK2468292T3/da active
- 2007-04-27 NZ NZ572255A patent/NZ572255A/en not_active IP Right Cessation
- 2007-04-27 BR BRPI0710959A patent/BRPI0710959B8/pt not_active IP Right Cessation
- 2007-04-27 CA CA2771087A patent/CA2771087C/en not_active Expired - Fee Related
- 2007-04-27 AU AU2007244004A patent/AU2007244004B2/en not_active Ceased
- 2007-04-27 ES ES12157100T patent/ES2773945T3/es active Active
- 2007-04-27 MX MX2008013769A patent/MX2008013769A/es active IP Right Grant
- 2007-04-27 RU RU2008146733/15A patent/RU2458703C2/ru active
- 2007-04-27 CN CN200780014996.XA patent/CN101432013B/zh not_active Expired - Fee Related
- 2007-04-27 EP EP12157100.4A patent/EP2468292B8/en active Active
- 2007-04-27 ES ES07748079.6T patent/ES2561945T3/es active Active
- 2007-04-27 NZ NZ598426A patent/NZ598426A/xx not_active IP Right Cessation
- 2007-04-27 KR KR1020087029053A patent/KR20090040404A/ko not_active Ceased
- 2007-04-27 PL PL12157100T patent/PL2468292T3/pl unknown
- 2007-04-27 WO PCT/SE2007/000414 patent/WO2007126364A2/en not_active Ceased
- 2007-04-27 EP EP07748079.6A patent/EP2015767B1/en not_active Not-in-force
- 2007-04-27 JP JP2009507632A patent/JP5284948B2/ja not_active Expired - Fee Related
- 2007-04-27 CA CA2650344A patent/CA2650344C/en not_active Expired - Fee Related
- 2007-04-27 SG SG201102876-8A patent/SG171602A1/en unknown
- 2007-04-27 DK DK07748079.6T patent/DK2015767T3/en active
-
2008
- 2008-10-22 IL IL194773A patent/IL194773A/en active IP Right Grant
- 2008-10-23 ZA ZA200809115A patent/ZA200809115B/xx unknown
- 2008-10-27 US US12/289,388 patent/US8207296B2/en not_active Expired - Fee Related
-
2012
- 2012-03-05 JP JP2012047547A patent/JP2012153695A/ja active Pending
- 2012-05-11 US US13/469,838 patent/US9000125B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL194773A (en) | Use of antisecretory protein for the preparation of a pharmaceutical preparation for the treatment of high intraocular pressure | |
| IL192944A0 (en) | THE USE OF AN ANTI-EpCAM ANTIBODY FOR THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION | |
| ZA200808178B (en) | Imidazolothiazole compounds for the treatment of disease | |
| EP2020960A4 (en) | INTRAOCULAR CAMERA FOR NETWORK SKIN PROTESTS | |
| IL193604A (en) | Use of human anti-22 @ il antibodies for @ preparation | |
| IL193747A0 (en) | New therapeutic combinations for the treatment of depression | |
| IL176629A0 (en) | Sulfonamide derivatives for the treatment of diseases | |
| IL198744A0 (en) | Novel antiproliferation antibodies | |
| AP2006003669A0 (en) | Sulfonamide derivatives for the treatment of diseases | |
| ZA200808429B (en) | Implants for the treatment of dopamine associated states | |
| IL194961A0 (en) | Compounds a-r-x for the manufacture of pharmaceutical preparations | |
| IL196667A (en) | Use of peptides to prepare a drug to treat inflammation | |
| IL192415A0 (en) | Pharmaceutical composition for the treatment of nail diseases | |
| PL2037950T3 (pl) | Dodatkowe zastosowania medyczne białka antysekrecyjnego | |
| EP2213303A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF CATARACT | |
| EP1922345A4 (en) | PROCESS FOR THE PREPARATION OF COPOLYMER-1 | |
| IL198941A0 (en) | Isosorbide mononitrate derivatives for the treatment of ocular hypertension | |
| GB0605376D0 (en) | Preparation for the relief of disease | |
| HU0500145D0 (en) | Composition for the treatment of oral diseases | |
| EP1864671A4 (en) | USE OF HYDROCHLORIC ACID FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF HYPERTENSION | |
| GB0610012D0 (en) | Joint prosthesis | |
| EP2056811B8 (en) | Modafinil-based treatment for premature ejaculation | |
| SI1927353T1 (sl) | Zdravilo za bolezni roženice | |
| AU2007907021A0 (en) | Antibodies for the treatment of periodontal disease | |
| IL186916A0 (en) | Use of insp052 polypeptide for the preparation of a medicament for treating diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed |